Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia.

IF 4 2区 医学 Q1 PSYCHIATRY Australian and New Zealand Journal of Psychiatry Pub Date : 2024-10-01 Epub Date: 2024-06-22 DOI:10.1177/00048674241261779
Zohaib Nadeem, Stephen Parker, Hugh McGovern, Lena Kl Oestreich
{"title":"Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia.","authors":"Zohaib Nadeem, Stephen Parker, Hugh McGovern, Lena Kl Oestreich","doi":"10.1177/00048674241261779","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Despite rapid advances in psychedelic sciences and the increasing number of countries legalizing psychedelics for the treatment of mental illnesses, the attitudes, knowledge and readiness of both mental health consumers and the general population remain largely unknown.</p><p><strong>Methods: </strong>A cross-sectional survey was conducted among Australians, targeting individuals with mental illness as potential mental health service users. A sub-sample of individuals free of mental illness was also surveyed to assess attitudes in the general population. Participants completed the Attitudes on Psychedelics Questionnaire, the Basic Knowledge of Psychedelics Test and a questionnaire by Corrigan et al. to capture attitudes toward psychedelic therapy by mental health service users.</p><p><strong>Results: </strong>Of the 502 respondents, 64.5% self-identified as having a mental illness. A significant proportion favored legalizing psychedelics for medical use (43%) and were open to their use (52.4%), yet fewer viewed their effects positively (24%) or considered them safe (33%). Most participants reported to be psychedelic naive (61%). Participants with mental illness had significantly more experience with psychedelics than participant free of mental illness (44.1% vs 29.7%). Experience, perceived knowledge and actual knowledge significantly predicted attitudes toward legalization, effects, risks and openness to psychedelics.</p><p><strong>Conclusions: </strong>While a large proportion of Australians are in favor of legalizing psychedelics for medical purposes, concerns about safety remain. People with self-identified mental illness, those with previous recreational psychedelic experience and those with greater knowledge of psychedelics were more likely to have positive attitudes toward psychedelics and psychedelic-assisted therapy.</p>","PeriodicalId":8589,"journal":{"name":"Australian and New Zealand Journal of Psychiatry","volume":" ","pages":"904-913"},"PeriodicalIF":4.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11420588/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian and New Zealand Journal of Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00048674241261779","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/22 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Despite rapid advances in psychedelic sciences and the increasing number of countries legalizing psychedelics for the treatment of mental illnesses, the attitudes, knowledge and readiness of both mental health consumers and the general population remain largely unknown.

Methods: A cross-sectional survey was conducted among Australians, targeting individuals with mental illness as potential mental health service users. A sub-sample of individuals free of mental illness was also surveyed to assess attitudes in the general population. Participants completed the Attitudes on Psychedelics Questionnaire, the Basic Knowledge of Psychedelics Test and a questionnaire by Corrigan et al. to capture attitudes toward psychedelic therapy by mental health service users.

Results: Of the 502 respondents, 64.5% self-identified as having a mental illness. A significant proportion favored legalizing psychedelics for medical use (43%) and were open to their use (52.4%), yet fewer viewed their effects positively (24%) or considered them safe (33%). Most participants reported to be psychedelic naive (61%). Participants with mental illness had significantly more experience with psychedelics than participant free of mental illness (44.1% vs 29.7%). Experience, perceived knowledge and actual knowledge significantly predicted attitudes toward legalization, effects, risks and openness to psychedelics.

Conclusions: While a large proportion of Australians are in favor of legalizing psychedelics for medical purposes, concerns about safety remain. People with self-identified mental illness, those with previous recreational psychedelic experience and those with greater knowledge of psychedelics were more likely to have positive attitudes toward psychedelics and psychedelic-assisted therapy.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
澳大利亚潜在心理健康服务使用者和普通民众对迷幻剂和迷幻剂辅助疗法的态度。
目的:尽管迷幻剂科学发展迅速,而且越来越多的国家将迷幻剂合法化用于治疗精神疾病,但精神健康消费者和普通民众对迷幻剂的态度、知识和准备程度在很大程度上仍不为人所知:方法:对澳大利亚人进行了一次横断面调查,调查对象是作为潜在精神健康服务使用者的精神疾病患者。此外,还对无精神疾病的个人进行了子样本调查,以评估普通人群的态度。参与者填写了《对迷幻药的态度问卷》、《迷幻药基本知识测试》和科里根等人的问卷,以了解精神健康服务使用者对迷幻药疗法的态度:结果:在 502 名受访者中,64.5% 的人自称患有精神疾病。相当一部分人赞成将迷幻剂合法化用于医疗用途(43%),并对迷幻剂的使用持开放态度(52.4%),但对其效果持积极看法(24%)或认为其安全的人较少(33%)。大多数参与者表示自己对迷幻药还不了解(61%)。患有精神疾病的参与者使用迷幻药的经验明显多于没有精神疾病的参与者(44.1% 对 29.7%)。经验、感知知识和实际知识对迷幻药合法化的态度、效果、风险和开放程度有明显的预测作用:尽管大部分澳大利亚人赞成将迷幻药合法化用于医疗目的,但对其安全性的担忧依然存在。自我认定患有精神疾病的人、曾有过迷幻药娱乐经历的人以及对迷幻药有更多了解的人更有可能对迷幻药和迷幻药辅助疗法持积极态度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
8.00
自引率
2.20%
发文量
149
审稿时长
6-12 weeks
期刊介绍: Australian & New Zealand Journal of Psychiatry is the official Journal of The Royal Australian and New Zealand College of Psychiatrists (RANZCP). The Australian & New Zealand Journal of Psychiatry is a monthly journal publishing original articles which describe research or report opinions of interest to psychiatrists. These contributions may be presented as original research, reviews, perspectives, commentaries and letters to the editor. The Australian & New Zealand Journal of Psychiatry is the leading psychiatry journal of the Asia-Pacific region.
期刊最新文献
Self-poisoning in young Australians: The impact of COVID-19 and recent trends following easing of restrictions. Letters to the Editor: Differential effects of access restriction to a highway bridge on suicide numbers by jumping. Extending the reach of involuntary treatment to substance use disorders: Is it 'compassionate' or coercive care? Policy implications of the 2020-22 Australian study of mental health and wellbeing. Glutamatergic neurotransmission in schizophrenia: A systematic review and quantitative synthesis of proton magnetic resonance spectroscopy studies across schizophrenia spectrum disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1